These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 26821209)
1. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways. Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209 [TBL] [Abstract][Full Text] [Related]
2. Regulation of docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C. Mhaidat NM; Thorne RF; Zhang XD; Hersey P Mol Cancer Res; 2007 Oct; 5(10):1073-81. PubMed ID: 17951407 [TBL] [Abstract][Full Text] [Related]
3. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P. Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060 [TBL] [Abstract][Full Text] [Related]
4. PKCδ signalling regulates SR-A and CD36 expression and foam cell formation. Lin CS; Lin FY; Ho LJ; Tsai CS; Cheng SM; Wu WL; Huang CY; Lian CH; Yang SP; Lai JH Cardiovasc Res; 2012 Aug; 95(3):346-55. PubMed ID: 22687273 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase C regulates human pluripotent stem cell self-renewal. Kinehara M; Kawamura S; Tateyama D; Suga M; Matsumura H; Mimura S; Hirayama N; Hirata M; Uchio-Yamada K; Kohara A; Yanagihara K; Furue MK PLoS One; 2013; 8(1):e54122. PubMed ID: 23349801 [TBL] [Abstract][Full Text] [Related]
6. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016 [TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms. van der Merwe JQ; Moreau F; MacNaughton WK Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1258-66. PubMed ID: 19359428 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria. Nuñez RE; Javadov S; Escobales N Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739 [TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line. Huang LH; Chung HY; Su HM BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029 [TBL] [Abstract][Full Text] [Related]
10. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. Menendez JA; Lupu R; Colomer R Eur J Cancer Prev; 2005 Jun; 14(3):263-70. PubMed ID: 15901996 [TBL] [Abstract][Full Text] [Related]
11. PTH1 receptor is involved in mediating cellular response to long-chain polyunsaturated fatty acids. Candelario J; Tavakoli H; Chachisvilis M PLoS One; 2012; 7(12):e52583. PubMed ID: 23300710 [TBL] [Abstract][Full Text] [Related]
12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
13. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway. German OL; Insua MF; Gentili C; Rotstein NP; Politi LE J Neurochem; 2006 Sep; 98(5):1507-20. PubMed ID: 16923163 [TBL] [Abstract][Full Text] [Related]
14. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation. Jang K; Kim M; Seo HS; Shin I Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988 [TBL] [Abstract][Full Text] [Related]
15. Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells. Ko JC; Ciou SC; Jhan JY; Cheng CM; Su YJ; Chuang SM; Lin ST; Chang CC; Lin YW Mol Cancer Res; 2009 Aug; 7(8):1378-89. PubMed ID: 19671683 [TBL] [Abstract][Full Text] [Related]
16. Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins. Dineva IK; Zaharieva MM; Konstantinov SM; Eibl H; Berger MR J Cancer Res Clin Oncol; 2012 Nov; 138(11):1909-17. PubMed ID: 22752602 [TBL] [Abstract][Full Text] [Related]
17. Protein kinase C (PKC)-delta/-epsilon mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin. Greco S; Storelli C; Marsigliante S J Endocrinol; 2006 Jan; 188(1):79-89. PubMed ID: 16394177 [TBL] [Abstract][Full Text] [Related]
18. Persistent activation of Akt or ERK prevents the toxicity induced by saturated and polyunsaturated fatty acids in RINm5F β-cells. Simon MN; Azevedo-Martins AK; Amanso AM; Carvalho CR; Curi R Toxicol In Vitro; 2008 Jun; 22(4):1018-24. PubMed ID: 18395405 [TBL] [Abstract][Full Text] [Related]
19. Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia. Nomura T; Yamasaki M; Hirai K; Inoue T; Sato R; Matsuura K; Moriyama M; Sato F; Mimata H Mol Cancer; 2013 Apr; 12():27. PubMed ID: 23566222 [TBL] [Abstract][Full Text] [Related]
20. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma. Guenther MK; Graab U; Fulda S Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]